戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 emain, particularly in the identification of secondary adrenal insufficiency.
2 0.45 (CI, 0.30 to 0.60) for the diagnosis of secondary adrenal insufficiency.
3 endocrine evaluation of suspected primary or secondary adrenal insufficiency.
4 lity is reported in patients with primary or secondary adrenal insufficiency.
5 s did not differ significantly (P > 0.5) for secondary adrenal insufficiency.
6 fficiency (250-microg cosyntropin test), and secondary adrenal insufficiency (1-microg cosyntropin te
7 insufficiency (250-microg cosyntropin test), secondary adrenal insufficiency (250-microg cosyntropin
8                         Although primary and secondary adrenal insufficiency are rare, affecting less
9                         Although primary and secondary adrenal insufficiency are rare, glucocorticoid
10                Four of the nine patients had secondary adrenal insufficiency as determined by a norma
11 moval of ACTH or cortisol-secreting tumours, secondary adrenal insufficiency ensues because of the pr
12 y was significantly greater than the AUC for secondary adrenal insufficiency for the high-dose cosynt
13                             The frequency of secondary adrenal insufficiency in sepsis remains open t
14                                              Secondary adrenal insufficiency is caused by disorders a
15 , but the lower sensitivity in patients with secondary adrenal insufficiency necessitates use of test
16                                          For secondary adrenal insufficiency, only studies that strat
17 es with fewer than 5 persons with primary or secondary adrenal insufficiency or with fewer than 10 pe
18                    Of the four patients with secondary adrenal insufficiency, two had a history of am